Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

FK 480

Known as: FK480 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Inhibitory effects of a newly developed benzodiazepine derivative (S)-N-[1-(2-fluorophenyl)-3,4,6,7-tetrahydro-4-oxo-pyrrolo-[3,2… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
Unlike in rodents, CCK has not been established as a physiological regulator in avian exocrine pancreatic secretion. In the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
We investigated hepatic in vitro intrinsic clearance (CL(int,in vitro)) in freshly isolated or cryopreserved hepatocytes and… Expand
  • figure 1
  • table 2
  • table 5
  • figure 2
  • table 3
Is this relevant?
2002
2002
The aim of this study was to evaluate pancreatic juice secretion of calves in the first postnatal days, and determine a potential… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
We investigated the quantitative prediction of human hepatic metabolic clearance from in vitro experiments focusing on cytochrome… Expand
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?
1999
1999
The aim of the present study was to investigate the role of CCK on the upper gut and pancreas microstructure and on pancreatic… Expand
Is this relevant?
1998
1998
Abstract Previously, we observed that pancreatic exocrine secretion was strongly enhanced after duodenal administration of… Expand
  • table 1
  • table II
  • figure 1
  • figure 1
  • figure 7
Is this relevant?
1996
1996
Cholecystokinin (CCK) is located in the brain and the spinal cord, and CCK antagonist is reported to enhance the analgesic effect… Expand
Is this relevant?
1995
1995
The effect of a new cholecystokinin (CCK)-A receptor antagonist, FK480, developed in Japan, on pancreatic exocrine secretion… Expand
Is this relevant?
1994
1994
FK480 is a new synthetic non-peptide antagonist of cholecystokinin (CCK)-A receptors. The dosage form of FK480 is a soft capsule… Expand
Is this relevant?